-
Je něco špatně v tomto záznamu ?
Electrospinning of diosmin from aqueous solutions for improved dissolution and oral absorption
P. Vrbata, P. Berka, D. Stránská, P. Doležal, M. Lázníček,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- aplikace orální MeSH
- diosmin aplikace a dávkování krev chemie farmakokinetika MeSH
- intestinální absorpce MeSH
- nanovlákna aplikace a dávkování chemie MeSH
- nosiče léků aplikace a dávkování chemie farmakokinetika MeSH
- potkani Wistar MeSH
- příprava léků metody MeSH
- rozpustnost MeSH
- roztoky MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
A nanofibrous membrane carrier for nearly water insoluble drug diosmin was formulated. The aim of this study was to evaluate the drug release and dissolution properties in an aqueous buffer of pH 7.8, and to compare the suitability of the drug carrier with the available drug forms and screen diosmin absorption extent. The membranes were produced from HPC/PVA/PEO-drug water solutions and then evaluated by SEM and DSC measurements. The results showed that diosmin was incorporated within the nanofibers in an amorphous state, and/or as a solid dispersion. The results of in vitro release experiments excerpt a very fast release of the drug, followed by the formation of an over saturated solution and partial precipitation of the drug (a "spring" effect). The enormous increases in dissolution of the drug from a nanofibrous carrier, compared to a micronized and crystalline form, was achieved. The in vivo bioavailability study carried out on rats showed higher initial drug plasma levels and higher AUC values after administration of the nanofibrous drug formulation, compared to the micronized form. The results of the study demonstrated that the improvement of the diosmin in vitro dissolution also brought the enhanced in vivo absorption extent of the drug.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15023201
- 003
- CZ-PrNML
- 005
- 20250312123752.0
- 007
- ta
- 008
- 150709s2014 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2014.07.017 $2 doi
- 035 __
- $a (PubMed)25066074
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Vrbata, Petr $u Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Czech republic.
- 245 10
- $a Electrospinning of diosmin from aqueous solutions for improved dissolution and oral absorption / $c P. Vrbata, P. Berka, D. Stránská, P. Doležal, M. Lázníček,
- 520 9_
- $a A nanofibrous membrane carrier for nearly water insoluble drug diosmin was formulated. The aim of this study was to evaluate the drug release and dissolution properties in an aqueous buffer of pH 7.8, and to compare the suitability of the drug carrier with the available drug forms and screen diosmin absorption extent. The membranes were produced from HPC/PVA/PEO-drug water solutions and then evaluated by SEM and DSC measurements. The results showed that diosmin was incorporated within the nanofibers in an amorphous state, and/or as a solid dispersion. The results of in vitro release experiments excerpt a very fast release of the drug, followed by the formation of an over saturated solution and partial precipitation of the drug (a "spring" effect). The enormous increases in dissolution of the drug from a nanofibrous carrier, compared to a micronized and crystalline form, was achieved. The in vivo bioavailability study carried out on rats showed higher initial drug plasma levels and higher AUC values after administration of the nanofibrous drug formulation, compared to the micronized form. The results of the study demonstrated that the improvement of the diosmin in vitro dissolution also brought the enhanced in vivo absorption extent of the drug.
- 650 _2
- $a aplikace orální $7 D000284
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a diosmin $x aplikace a dávkování $x krev $x chemie $x farmakokinetika $7 D004145
- 650 _2
- $a nosiče léků $x aplikace a dávkování $x chemie $x farmakokinetika $7 D004337
- 650 _2
- $a příprava léků $x metody $7 D004339
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a intestinální absorpce $7 D007408
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nanovlákna $x aplikace a dávkování $x chemie $7 D057139
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a roztoky $7 D012996
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Berka, Pavel $u Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Czech republic. $7 _AN057583
- 700 1_
- $a Stránská, Denisa $u Elmarco Ltd.Co., Liberec, Czech Republic.
- 700 1_
- $a Doležal, Pavel $u Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Czech republic. Electronic address: dolezal@faf.cuni.cz.
- 700 1_
- $a Lázníček, Milan $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Czech Republic.
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 473, č. 1-2 (2014), s. 407-13
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25066074 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20250312123759 $b ABA008
- 999 __
- $a ok $b bmc $g 1083539 $s 906194
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 473 $c 1-2 $d 407-13 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
- LZP __
- $a Pubmed-20150709